The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
100 jobs Number of planned job losses
Announcement Date
2 October 2008
Employment effect (start)
31 December 2009
Foreseen end date
31 December 2009
Description
DSM Anti-Infectives is the world’s leading supplier of active pharmaceutical ingredients such as Amoxicillin, Ampicillin, Cephalexin and Cefadroxil; the worlds most widely used broad spectrum antibiotics for combating bacterial infections. In June 2007, DSM Anti-Infectives announced the outcome of its strategic review. Through a partnering strategy combined with innovation initiatives and restructuring measures, DSM believes the greatest value will be generated. As part of the review, clavulanic acid was not considered a long term strategic product for the group. Since June 2007 several options were evaluated, resulting in the decision to close the site in Strängnäs. The production will be terminated and the factory will close down at the end of 2009.
Eurofound (2008), DSM Anti-Infectives, Closure in Sweden, factsheet number 67201, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/67201.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
